TreeWAS – Variant ID: rs16852912

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
R35 Polyuria	0.000	0.922	0.078
N13.3 Other and unspecified hydronephrosis	0.011	0.989	0.000
N13 Obstructive and reflux uropathy	0.010	0.990	0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.010	0.990	0.000
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.010	0.990	0.000
C34.9 Bronchus or lung, unspecified	0.000	0.991	0.009
R30-R39 Symptoms and signs involving the urinary system	0.000	0.992	0.008
N13.9 Obstructive and reflux uropathy, unspecified	0.008	0.992	0.000
N13.6 Pyonephrosis	0.008	0.992	0.000
R34 Anuria and oliguria	0.000	0.992	0.008
N13.4 Hydroureter	0.007	0.993	0.000
N13.7 Vesicoureteral-reflux-associated uropathy	0.007	0.993	0.000
C34.3 Lower lobe, bronchus or lung	0.000	0.993	0.007
C34 Malignant neoplasm of bronchus and lung	0.000	0.993	0.007
R30 Pain associated with micturition	0.000	0.993	0.007
R36 Urethral discharge	0.000	0.994	0.006
R30.9 Painful micturition, unspecified	0.000	0.994	0.006
Z13.0 Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.994	0.006
R39 Other symptoms and signs involving the urinary system	0.000	0.994	0.006
C34.0 Main bronchus	0.000	0.994	0.006
N13.8 Other obstructive and reflux uropathy	0.006	0.994	0.000
N81.1 Cystocele	0.006	0.994	0.000
R39.1 Other difficulties with micturition	0.000	0.994	0.006
N13.5 Kinking and stricture of ureter without hydronephrosis	0.006	0.994	0.000
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.005	0.994	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.005	0.995	0.000
H65 Nonsuppurative otitis media	0.005	0.995	0.000
C34.8 Overlapping lesion of bronchus and lung	0.000	0.995	0.005
R30.1 Vesical tenesmus	0.000	0.995	0.005
C34.2 Middle lobe, bronchus or lung	0.000	0.995	0.005
N81.5 Vaginal enterocele	0.005	0.995	0.000
R31 Unspecified haematuria	0.000	0.995	0.005
H66.9 Otitis media, unspecified	0.000	0.995	0.005
H72 Perforation of tympanic membrane	0.005	0.995	0.000
R30.0 Dysuria	0.000	0.995	0.005
H65.3 Chronic mucoid otitis media	0.005	0.995	0.000
H72.8 Other perforations of tympanic membrane	0.005	0.995	0.000
C67 Malignant neoplasm of bladder	0.005	0.995	0.000
C67.3 Anterior wall of bladder	0.005	0.995	0.000
C67.6 Ureteric orifice	0.005	0.995	0.000
H25.8 Other senile cataract	0.000	0.995	0.005
C67.5 Bladder neck	0.005	0.995	0.000
H72.0 Central perforation of tympanic membrane	0.005	0.995	0.000
H65-H75 Diseases of middle ear and mastoid	0.005	0.995	0.000
H72.1 Attic perforation of tympanic membrane	0.005	0.995	0.000
H81.1 Benign paroxysmal vertigo	0.005	0.995	0.000
R39.2 Extrarenal uraemia	0.000	0.995	0.004
R39.0 Extravasation of urine	0.000	0.995	0.004
C67.2 Lateral wall of bladder	0.004	0.996	0.000
H81 Disorders of vestibular function	0.004	0.996	0.000
C67.4 Posterior wall of bladder	0.004	0.996	0.000
H81.0 Meniere's disease	0.004	0.996	0.000
H65.4 Other chronic nonsuppurative otitis media	0.004	0.996	0.000
C67.1 Dome of bladder	0.004	0.996	0.000
H90.3 Sensorineural hearing loss, bilateral	0.004	0.996	0.000
H65.2 Chronic serous otitis media	0.004	0.996	0.000
H65.1 Other acute nonsuppurative otitis media	0.004	0.996	0.000
H65.0 Acute serous otitis media	0.004	0.996	0.000
F60.9 Personality disorder, unspecified	0.004	0.996	0.000
N10-N16 Renal tubulo-interstitial diseases	0.004	0.996	0.000
C67.0 Trigone of bladder	0.004	0.996	0.000
C34.1 Upper lobe, bronchus or lung	0.000	0.996	0.004
C67.8 Overlapping lesion of bladder	0.004	0.996	0.000
H69 Other disorders of Eustachian tube	0.004	0.996	0.000
H72.2 Other marginal perforations of tympanic membrane	0.004	0.996	0.000
N10 Acute tubulo-interstitial nephritis	0.004	0.996	0.000
C67.7 Urachus	0.004	0.996	0.000
H66 Suppurative and unspecified otitis media	0.002	0.996	0.002
H74 Other disorders of middle ear and mastoid	0.004	0.996	0.000
F60.3 Emotionally unstable personality disorder	0.004	0.996	0.000
A63.0 Anogenital (venereal) warts	0.004	0.996	0.000
F60 Specific personality disorders	0.004	0.996	0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.003	0.996	0.000
H68 Eustachian salpingitis and obstruction	0.003	0.996	0.000
H67 Otitis media in diseases classified elsewhere	0.003	0.996	0.000
H69.9 Eustachian tube disorder, unspecified	0.003	0.996	0.000
H80-H83 Diseases of inner ear	0.003	0.997	0.000
H90 Conductive and sensorineural hearing loss	0.003	0.997	0.000
H81.9 Disorder of vestibular function, unspecified	0.003	0.997	0.000
H81.8 Other disorders of vestibular function	0.003	0.997	0.000
H81.4 Vertigo of central origin	0.003	0.997	0.000
H81.3 Other peripheral vertigo	0.003	0.997	0.000
H81.2 Vestibular neuronitis	0.003	0.997	0.000
H71 Cholesteatoma of middle ear	0.003	0.997	0.000
H70 Mastoiditis and related conditions	0.003	0.997	0.000
N11 Chronic tubulo-interstitial nephritis	0.003	0.997	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.003	0.997	0.000
H74.9 Disorder of middle ear and mastoid, unspecified	0.003	0.997	0.000
H73 Other disorders of tympanic membrane	0.003	0.997	0.000
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.003	0.997	0.000
N15 Other renal tubulo-interstitial diseases	0.003	0.997	0.000
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
H69.8 Other specified disorders of Eustachian tube	0.003	0.997	0.000
H69.0 Patulous Eustachian tube	0.003	0.997	0.000
Z13 Special screening examination for other diseases and disorders	0.000	0.997	0.003
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.003	0.997	0.000
H74.0 Tympanosclerosis	0.003	0.997	0.000
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.003	0.997	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.997	0.003
H74.8 Other specified disorders of middle ear and mastoid	0.003	0.997	0.000
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.003	0.997	0.000
Z13.9 Special screening examination, unspecified	0.000	0.997	0.003
H66.1 Chronic tubotympanic suppurative otitis media	0.002	0.997	0.001
H74.3 Other acquired abnormalities of ear ossicles	0.003	0.997	0.000
Chapter VIII Diseases of the ear and mastoid process	0.003	0.997	0.000
H66.4 Suppurative otitis media, unspecified	0.002	0.997	0.001
H66.2 Chronic atticoantral suppurative otitis media	0.002	0.997	0.001
H66.0 Acute suppurative otitis media	0.002	0.997	0.001
H74.2 Discontinuity and dislocation of ear ossicles	0.003	0.997	0.000
H74.1 Adhesive middle ear disease	0.003	0.997	0.000
N81 Female genital prolapse	0.003	0.997	0.000
F60.8 Other specific personality disorders	0.003	0.997	0.000
F60.7 Dependent personality disorder	0.003	0.997	0.000
F60.6 Anxious [avoidant] personality disorder	0.003	0.997	0.000
F60.5 Anankastic personality disorder	0.003	0.997	0.000
F60.4 Histrionic personality disorder	0.003	0.997	0.000
F60.2 Dissocial personality disorder	0.003	0.997	0.000
F60.1 Schizoid personality disorder	0.003	0.997	0.000
F60.0 Paranoid personality disorder	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.997	0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.003	0.997	0.000
H67.8 Otitis media in other diseases classified elsewhere	0.003	0.997	0.000
H67.1 Otitis media in viral diseases classified elsewhere	0.003	0.997	0.000
H67.0 Otitis media in bacterial diseases classified elsewhere	0.003	0.997	0.000
H68.1 Obstruction of Eustachian tube	0.003	0.997	0.000
H68.0 Eustachian salpingitis	0.003	0.997	0.000
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere	0.003	0.997	0.000
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
O16 Unspecified maternal hypertension	0.003	0.997	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.000	0.997	0.003
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.997	0.000
H82 Vertiginous syndromes in diseases classified elsewhere	0.003	0.997	0.000
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.003	0.997	0.000
H90.6 Mixed conductive and sensorineural hearing loss, bilateral	0.003	0.997	0.000
N81.4 Uterovaginal prolapse, unspecified	0.003	0.997	0.000
N11.8 Other chronic tubulo-interstitial nephritis	0.003	0.997	0.000
N11.1 Chronic obstructive pyelonephritis	0.003	0.997	0.000
N11.0 Nonobstructive reflux-associated chronic pyelonephritis	0.003	0.997	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
H80 Otosclerosis	0.003	0.997	0.000
H70.8 Other mastoiditis and related conditions	0.002	0.997	0.000
H70.2 Petrositis	0.002	0.997	0.000
H70.1 Chronic mastoiditis	0.002	0.997	0.000
H70.0 Acute mastoiditis	0.002	0.997	0.000
D68.2 Hereditary deficiency of other clotting factors	0.000	0.997	0.003
H90.2 Conductive hearing loss, unspecified	0.003	0.997	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
H73.9 Disorder of tympanic membrane, unspecified	0.002	0.997	0.000
H73.1 Chronic myringitis	0.002	0.997	0.000
H73.0 Acute myringitis	0.002	0.997	0.000
H52.1 Myopia	0.000	0.997	0.003
N14.4 Toxic nephropathy, not elsewhere classified	0.002	0.997	0.000
N14.3 Nephropathy induced by heavy metals	0.002	0.997	0.000
N14.2 Nephropathy induced by unspecified drug, medicament or biological substance	0.002	0.997	0.000
N14.1 Nephropathy induced by other drugs, medicaments and biological substances	0.002	0.997	0.000
N14.0 Analgesic nephropathy	0.002	0.997	0.000
N15.9 Renal tubulo-interstitial disease, unspecified	0.002	0.997	0.000
N15.8 Other specified renal tubulo-interstitial diseases	0.002	0.997	0.000
N15.1 Renal and perinephric abscess	0.002	0.997	0.000
N15.0 Balkan nephropathy	0.002	0.997	0.000
N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere	0.002	0.997	0.000
N16.5 Renal tubulo-interstitial disorders in transplant rejection	0.002	0.997	0.000
N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders	0.002	0.997	0.000
N16.3 Renal tubulo-interstitial disorders in metabolic diseases	0.002	0.997	0.000
N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism	0.002	0.997	0.000
N16.1 Renal tubulo-interstitial disorders in neoplastic diseases	0.002	0.997	0.000
N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere	0.002	0.997	0.000
H66.3 Other chronic suppurative otitis media	0.001	0.997	0.001
H90.0 Conductive hearing loss, bilateral	0.002	0.997	0.000
Z13.6 Special screening examination for cardiovascular disorders	0.000	0.997	0.003
T46.1 Calcium-channel blockers	0.002	0.997	0.000
Z13.8 Special screening examination for other specified diseases and disorders	0.000	0.997	0.002
Z13.7 Special screening examination for congenital malformations, deformations and chromosomal abnormalities	0.000	0.997	0.002
Z13.4 Special screening examination for certain developmental disorders in childhood	0.000	0.997	0.002
Z13.2 Special screening examination for nutritional disorders	0.000	0.997	0.002
K31.7 Polyp of stomach and duodenum	0.000	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.003	0.997	0.000
Z13.3 Special screening examination for mental and behavioural disorders	0.000	0.998	0.002
H83 Other diseases of inner ear	0.002	0.998	0.000
H90-H95 Other disorders of ear	0.002	0.998	0.000
H70.9 Mastoiditis, unspecified	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
K62.0 Anal polyp	0.000	0.998	0.002
F45.8 Other somatoform disorders	0.002	0.998	0.000
N81.0 Female urethrocele	0.002	0.998	0.000
K51 Ulcerative colitis	0.000	0.998	0.002
H59.8 Other postprocedural disorders of eye and adnexa	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
T46.7 Peripheral vasodilators	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
E23.0 Hypopituitarism	0.000	0.998	0.002
Q21.1 Atrial septal defect	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.002	0.998	0.000
H74.4 Polyp of middle ear	0.002	0.998	0.000
D22.3 Melanocytic naevi of other and unspecified parts of face	0.000	0.998	0.002
Q21 Congenital malformations of cardiac septa	0.002	0.998	0.000
K51.5 Mucosal proctocolitis	0.000	0.998	0.002
M35.3 Polymyalgia rheumatica	0.000	0.998	0.002
T43.9 Psychotropic drug, unspecified	0.002	0.998	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.002	0.998	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.000	0.998	0.002
C38 Malignant neoplasm of heart, mediastinum and pleura	0.000	0.998	0.002
C31 Malignant neoplasm of accessory sinuses	0.000	0.998	0.002
C30 Malignant neoplasm of nasal cavity and middle ear	0.000	0.998	0.002
C37 Malignant neoplasm of thymus	0.000	0.998	0.002
C33 Malignant neoplasm of trachea	0.000	0.998	0.002
F60-F69 Disorders of adult personality and behaviour	0.002	0.998	0.000
Q28 Other congenital malformations of circulatory system	0.002	0.998	0.000
Q28.2 Arteriovenous malformation of cerebral vessels	0.002	0.998	0.000
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.000	0.998	0.002
Z13.5 Special screening examination for eye and ear disorders	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
H80.8 Other otosclerosis	0.002	0.998	0.000
H80.2 Cochlear otosclerosis	0.002	0.998	0.000
H80.1 Otosclerosis involving oval window, obliterative	0.002	0.998	0.000
H80.0 Otosclerosis involving oval window, nonobliterative	0.002	0.998	0.000
K51.4 Pseudopolyposis of colon	0.000	0.998	0.002
Q23 Congenital malformations of aortic and mitral valves	0.002	0.998	0.000
H73.8 Other specified disorders of tympanic membrane	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
A63 Other predominantly sexually transmitted diseases, not elsewhere classified	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.998	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.002	0.998	0.000
Q24 Other congenital malformations of heart	0.002	0.998	0.000
H80.9 Otosclerosis, unspecified	0.002	0.998	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.000	0.998	0.002
Q23.1 Congenital insufficiency of aortic valve	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.000	0.998	0.002
C32 Malignant neoplasm of larynx	0.000	0.998	0.002
Z13.1 Special screening examination for diabetes mellitus	0.000	0.998	0.002
S06.20 Diffuse brain injury (without open intracranial wound)	0.000	0.998	0.002
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.002	0.998	0.000
Z13.83 Encounter for screening for respiratory disorder NEC	0.000	0.998	0.002
Z13.82 Encounter for screening for musculoskeletal disorder	0.000	0.998	0.002
K21.0 Gastro-oesophageal reflux disease with oesophagitis	0.000	0.998	0.002
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.002	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
H83.9 Disease of inner ear, unspecified	0.002	0.998	0.000
H83.8 Other specified diseases of inner ear	0.002	0.998	0.000
H83.3 Noise effects on inner ear	0.002	0.998	0.000
H83.2 Labyrinthine dysfunction	0.002	0.998	0.000
H83.1 Labyrinthine fistula	0.002	0.998	0.000
Q24.8 Other specified congenital malformations of heart	0.002	0.998	0.000
H94 Other disorders of ear in diseases classified elsewhere	0.002	0.998	0.000
F69 Unspecified disorder of adult personality and behaviour	0.002	0.998	0.000
N81.3 Complete uterovaginal prolapse	0.002	0.998	0.000
H52 Disorders of refraction and accommodation	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
D68.5 Primary Thrombophilia	0.000	0.998	0.002
K51.1 Ulcerative (chronic) ileocolitis	0.000	0.998	0.002
C67.9 Bladder, unspecified	0.002	0.998	0.000
H52.3 Anisometropia and aniseikonia	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
Q26 Congenital malformations of great veins	0.002	0.998	0.000
Q25 Congenital malformations of great arteries	0.002	0.998	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.002	0.998	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.002	0.998	0.000
H90.5 Sensorineural hearing loss, unspecified	0.002	0.998	0.000
C30.1 Middle ear	0.000	0.998	0.002
C30.0 Nasal cavity	0.000	0.998	0.002
C31.9 Accessory sinus, unspecified	0.000	0.998	0.002
C31.8 Overlapping lesion of accessory sinuses	0.000	0.998	0.002
C31.3 Sphenoidal sinus	0.000	0.998	0.002
C31.2 Frontal sinus	0.000	0.998	0.002
C31.1 Ethmoidal sinus	0.000	0.998	0.002
C31.0 Maxillary sinus	0.000	0.998	0.002
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.000	0.998	0.002
C38.4 Pleura	0.000	0.998	0.002
C38.3 Mediastinum, part unspecified	0.000	0.998	0.002
C38.2 Posterior mediastinum	0.000	0.998	0.002
C38.1 Anterior mediastinum	0.000	0.998	0.002
C38.0 Heart	0.000	0.998	0.002
C39.9 Ill-defined sites within the respiratory system	0.000	0.998	0.002
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.000	0.998	0.002
C39.0 Upper respiratory tract, part unspecified	0.000	0.998	0.002
Q21.9 Congenital malformation of cardiac septum, unspecified	0.002	0.998	0.000
Q21.8 Other congenital malformations of cardiac septa	0.002	0.998	0.000
Q21.4 Aortopulmonary septal defect	0.002	0.998	0.000
Q21.3 Tetralogy of Fallot	0.002	0.998	0.000
Q21.2 Atrioventricular septal defect	0.002	0.998	0.000
Q21.0 Ventricular septal defect	0.002	0.998	0.000
K51.9 Ulcerative colitis, unspecified	0.000	0.998	0.002
T39.0 Salicylates	0.002	0.998	0.000
F68 Other disorders of adult personality and behaviour	0.002	0.998	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.002	0.998	0.000
F65 Disorders of sexual preference	0.002	0.998	0.000
F63 Habit and impulse disorders	0.002	0.998	0.000
F62 Enduring personality changes, not attributable to brain damage and disease	0.002	0.998	0.000
F61 Mixed and other personality disorders	0.002	0.998	0.000
K51.8 Other ulcerative colitis	0.000	0.998	0.002
Q23.0 Congenital stenosis of aortic valve	0.002	0.998	0.000
Q28.9 Congenital malformation of circulatory system, unspecified	0.002	0.998	0.000
Q28.8 Other specified congenital malformations of circulatory system	0.002	0.998	0.000
Q28.3 Other malformations of cerebral vessels	0.002	0.998	0.000
Q28.1 Other malformations of precerebral vessels	0.002	0.998	0.000
Q28.0 Arteriovenous malformation of precerebral vessels	0.002	0.998	0.000
D68 Other coagulation defects	0.000	0.998	0.002
F64 Gender identity disorders	0.002	0.998	0.000
Q27 Other congenital malformations of peripheral vascular system	0.002	0.998	0.000
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.002	0.998	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.002	0.998	0.000
Q23.4 Hypoplastic left heart syndrome	0.002	0.998	0.000
Q23.3 Congenital mitral insufficiency	0.002	0.998	0.000
Q23.2 Congenital mitral stenosis	0.002	0.998	0.000
H95.0 Recurrent cholesteatoma of postmastoidectomy cavity	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
F45 Somatoform disorders	0.002	0.998	0.000
C64-C68 Malignant neoplasms of urinary tract	0.002	0.998	0.000
A63.8 Other specified predominantly sexually transmitted diseases	0.002	0.998	0.000
N81.6 Rectocele	0.002	0.998	0.000
T43.2 Other and unspecified antidepressants	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
C65 Malignant neoplasm of renal pelvis	0.002	0.998	0.000
F45.0 Somatisation disorder	0.002	0.998	0.000
Q24.9 Congenital malformation of the heart, unspecified	0.002	0.998	0.000
Q24.6 Congenital heart block	0.002	0.998	0.000
Q24.5 Malformation of coronary vessels	0.002	0.998	0.000
Q24.4 Congenital subaortic stenosis	0.002	0.998	0.000
Q24.3 Pulmonary infundibular stenosis	0.002	0.998	0.000
Q24.2 Cor triatriatum	0.002	0.998	0.000
Q24.1 Levocardia	0.002	0.998	0.000
Q24.0 Dextrocardia	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.5 Cocaine	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
T40.1 Heroin	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
T45.5 Anticoagulants	0.002	0.998	0.000
C32.8 Overlapping lesion of larynx	0.000	0.998	0.002
C32.3 Laryngeal cartilage	0.000	0.998	0.002
C32.2 Subglottis	0.000	0.998	0.002
C32.0 Glottis	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
D68.8 Other specified coagulation defects	0.000	0.998	0.002
H95.9 Postprocedural disorder of ear and mastoid process, unspecified	0.002	0.998	0.000
H95.8 Other postprocedural disorders of ear and mastoid process	0.002	0.998	0.000
R04.2 Haemoptysis	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
T36.8 Other systemic antibiotics	0.002	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
T36.6 Rifamycins	0.002	0.998	0.000
T36.5 Aminoglycosides	0.002	0.998	0.000
T36.4 Tetracyclines	0.002	0.998	0.000
T36.3 Macrolides	0.002	0.998	0.000
T36.2 Chloramphenicol group	0.002	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.002	0.998	0.000
T36.0 Penicillins	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
T37.5 Antiviral drugs	0.002	0.998	0.000
T37.4 Anthelminthics	0.002	0.998	0.000
T37.3 Other antiprotozoal drugs	0.002	0.998	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
T37.1 Antimycobacterial drugs	0.002	0.998	0.000
T37.0 Sulphonamides	0.002	0.998	0.000
T41.5 Therapeutic gases	0.002	0.998	0.000
T41.4 Anaesthetic, unspecified	0.002	0.998	0.000
T41.3 Local anaesthetics	0.002	0.998	0.000
T41.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
T41.1 Intravenous anaesthetics	0.002	0.998	0.000
T41.0 Inhaled anaesthetics	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
T48.5 Anti-common-cold drugs	0.002	0.998	0.000
T48.4 Expectorants	0.002	0.998	0.000
T48.3 Antitussives	0.002	0.998	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
T48.0 Oxytocic drugs	0.002	0.998	0.000
T49.9 Topical agent, unspecified	0.002	0.998	0.000
T49.8 Other topical agents	0.002	0.998	0.000
T49.7 Dental drugs, topically applied	0.002	0.998	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
T49.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
T49.3 Emollients, demulcents and protectants	0.002	0.998	0.000
T49.2 Local astringents and local detergents	0.002	0.998	0.000
T49.1 Antipruritics	0.002	0.998	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
F45.9 Somatoform disorder, unspecified	0.002	0.998	0.000
H52.0 Hypermetropia	0.000	0.998	0.002
H94.8 Other specified disorders of ear in diseases classified elsewhere	0.001	0.998	0.000
H94.0 Acoustic neuritis in infectious and parasitic diseases classified elsewhere	0.001	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
K51.2 Ulcerative (chronic) proctitis	0.000	0.998	0.002
C32.1 Supraglottis	0.000	0.998	0.002
F22.0 Delusional disorder	0.002	0.998	0.000
H52.6 Other disorders of refraction	0.000	0.998	0.002
H52.5 Disorders of accommodation	0.000	0.998	0.002
H52.4 Presbyopia	0.000	0.998	0.002
H52.2 Astigmatism	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.001	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.001	0.998	0.000
T38.7 Androgens and anabolic congeners	0.001	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.001	0.998	0.000
T38.5 Other oestrogens and progestogens	0.001	0.998	0.000
T38.4 Oral contraceptives	0.001	0.998	0.000
T38.2 Antithyroid drugs	0.001	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.001	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.001	0.998	0.000
H83.0 Labyrinthitis	0.002	0.998	0.000
C32.9 Larynx, unspecified	0.000	0.998	0.001
Q20.9 Congenital malformation of cardiac chambers and connexions, unspecified	0.001	0.998	0.000
Q20.8 Other congenital malformations of cardiac chambers and connexions	0.001	0.998	0.000
Q20.6 Isomerism of atrial appendages	0.001	0.998	0.000
Q20.5 Discordant atrioventricular connexion	0.001	0.998	0.000
Q20.4 Double inlet ventricle	0.001	0.998	0.000
Q20.3 Discordant ventriculoarterial connexion	0.001	0.998	0.000
Q20.2 Double outlet left ventricle	0.001	0.998	0.000
Q20.1 Double outlet right ventricle	0.001	0.998	0.000
Q20.0 Common arterial trunk	0.001	0.998	0.000
Q22.9 Congenital malformation of tricuspid valve, unspecified	0.001	0.998	0.000
Q22.8 Other congenital malformations of tricuspid valve	0.001	0.998	0.000
Q22.6 Hypoplastic right heart syndrome	0.001	0.998	0.000
Q22.5 Ebstein's anomaly	0.001	0.998	0.000
Q22.4 Congenital tricuspid stenosis	0.001	0.998	0.000
Q22.3 Other congenital malformations of pulmonary valve	0.001	0.998	0.000
Q22.2 Congenital pulmonary valve insufficiency	0.001	0.998	0.000
Q22.1 Congenital pulmonary valve stenosis	0.001	0.998	0.000
Q22.0 Pulmonary valve atresia	0.001	0.998	0.000
Q25.9 Congenital malformation of great arteries, unspecified	0.001	0.998	0.000
Q25.8 Other congenital malformations of great arteries	0.001	0.998	0.000
Q25.7 Other congenital malformations of pulmonary artery	0.001	0.998	0.000
Q25.6 Stenosis of pulmonary artery	0.001	0.998	0.000
Q25.5 Atresia of pulmonary artery	0.001	0.998	0.000
Q25.4 Other congenital malformations of aorta	0.001	0.998	0.000
Q25.3 Stenosis of aorta	0.001	0.998	0.000
Q25.2 Atresia of aorta	0.001	0.998	0.000
Q25.1 Coarctation of aorta	0.001	0.998	0.000
Q25.0 Patent ductus arteriosus	0.001	0.998	0.000
Q26.9 Congenital malformation of great vein, unspecified	0.001	0.998	0.000
Q26.8 Other congenital malformations of great veins	0.001	0.998	0.000
Q26.6 Portal vein-hepatic artery fistula	0.001	0.998	0.000
Q26.5 Anomalous portal venous connexion	0.001	0.998	0.000
Q26.4 Anomalous pulmonary venous connexion, unspecified	0.001	0.998	0.000
Q26.3 Partial anomalous pulmonary venous connexion	0.001	0.998	0.000
Q26.2 Total anomalous pulmonary venous connexion	0.001	0.998	0.000
Q26.1 Persistent left superior vena cava	0.001	0.998	0.000
Q26.0 Congenital stenosis of vena cava	0.001	0.998	0.000
S06.6 Traumatic subarachnoid haemorrhage	0.000	0.998	0.002
S06.2 Diffuse brain injury	0.000	0.998	0.002
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
D68.9 Coagulation defect, unspecified	0.000	0.998	0.002
F62.9 Enduring personality change, unspecified	0.001	0.998	0.000
F62.8 Other enduring personality changes	0.001	0.998	0.000
F62.1 Enduring personality change after psychiatric illness	0.001	0.998	0.000
F62.0 Enduring personality change after catastrophic experience	0.001	0.998	0.000
F63.9 Habit and impulse disorder, unspecified	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations